You are here

Abbott Labs

Abbott Launches Non-Surgical Pain Treatment Device

Abbott Launches Non-Surgical Pain Treatment Device

Medical Devices and Diagnostics Industry

pain management

IonicRF Generator

Flag link:

Abbott’s Covid-19 antigen test shows promise in asymptomatics

Abbott’s Covid-19 antigen test shows promise in asymptomatics

EP Vantage

Flag link:

Abbott Strengthens Electrophysiology Portfolio with New Approvals

Abbott Strengthens Electrophysiology Portfolio with New Approvals

Medical Devices and Diagnostics Industry

cardiac mapping

elecrophysiology

Flag link:

Abbott Labs CEO: Covid-19 Testing Moves Beyond ‘Hospital Walls’ Into Airports, Retail Stores, Communities

Abbott Labs CEO: Covid-19 Testing Moves Beyond ‘Hospital Walls’ Into Airports, Retail Stores, Communities

Forbes

Flag link:

Demand For Abbott Labs Covid-19 Tests Eclipses 100 Million As Pandemic Rages On

Demand For Abbott Labs Covid-19 Tests Eclipses 100 Million As Pandemic Rages On

Forbes

Flag link:

Abbott’s Fast and Furious Pace with COVID-19-Related Tests Continues

Abbott’s Fast and Furious Pace with COVID-19-Related Tests Continues

Medical Devices and Diagnostics Industry

Emergency Use Authorization

Flag link:

Abbott Laboratories Says Its Rapid Coronavirus Test Correctly Identifies Positive Cases 95% of the Time

Abbott Laboratories Says Its Rapid Coronavirus Test Correctly Identifies Positive Cases 95% of the Time

Motley Fool

Flag link:

Abbott Labs to Sell 20.5 Million COVID-19 Antigen Tests to Canadian Government

Abbott Labs to Sell 20.5 Million COVID-19 Antigen Tests to Canadian Government

Motley Fool

Flag link:

Abbott Labs' New Coronavirus Diagnostic Will Reshape the Testing Market

Abbott Labs' New Coronavirus Diagnostic Will Reshape the Testing Market

Motley Fool

Flag link:

Abbott Wins European Approval for Latest MitraClip Heart Valve Device

Abbott Wins European Approval for Latest MitraClip Heart Valve Device

Motley Fool

Flag link:

Abbott Launches World's First Glucose Monitor for Athletes

Abbott Launches World's First Glucose Monitor for Athletes

Motley Fool

blood glucose monitoring

Flag link:

Abbott, Illumina, other medtechs shape guide conveying device risks to patients

Abbott, Illumina, other medtechs shape guide conveying device risks to patients

BioPharma Dive

Flag link:

FDA flags 428 spinal cord stimulator patient deaths, urges more tests before implant

FDA flags 428 spinal cord stimulator patient deaths, urges more tests before implant

Medtech Dive

spinal cord stimulator

Boston Scientific

Flag link:

Is Abbott Making a Comeback in the Resorbable Stent Market?

Is Abbott Making a Comeback in the Resorbable Stent Market?

Medical Devices and Diagnostics Industry

drug-eluting scaffold

bioresorbable stent

clinical trials

Flag link:

Report: Feds to send Abbott’s rapid tests to states for school reopenings

Report: Feds to send Abbott’s rapid tests to states for school reopenings

Mass Device

Flag link:

Abbott to Receive Order for 150 Million Rapid COVID-19 Tests

Abbott to Receive Order for 150 Million Rapid COVID-19 Tests

Motley Fool

government contracts

Flag link:

Abbott Receives FDA Authorization for a $5 App-Enabled 15-Minute COVID-19 Test

Abbott Receives FDA Authorization for a $5 App-Enabled 15-Minute COVID-19 Test

Motley Fool

Emergency Use Authorization

Flag link:

Medtronic acquired insulin pen startup Companion Medical to broaden its diabetes management tech

Medtronic acquired insulin pen startup Companion Medical to broaden its diabetes management tech

Business Insider

Companion Medical

artificial pancreas

Flag link:

Why A Covid-19 Vaccine Won't Halt Feverish Demand For Coronavirus Tests

Why A Covid-19 Vaccine Won't Halt Feverish Demand For Coronavirus Tests

Investors Business Daily

Flag link:

People can now control their Abbott neuromod device over their iPhone

People can now control their Abbott neuromod device over their iPhone

Mass Device

neuromodulators

Flag link:

Pages